Basel Medical Group Ltd [NASDAQ: BMGL] price plunged by -57.78 percent to reach at -$2.6.
Guru’s Opinion on Basel Medical Group Ltd [BMGL]:
The Average True Range (ATR) for Basel Medical Group Ltd is set at 0.72, with the Price to Sales ratio for BMGL stock in the period of the last 12 months amounting to 4.79. The Price to Book ratio for the last quarter was 5.53, with the Price to Cash per share for the same quarter was set at 0.08. Price to Free Cash Flow for BMGL in the course of the last twelve months was 19.19 with Quick ratio for the last quarter at 2.03.
BMGL Stock Performance Analysis:
Basel Medical Group Ltd [BMGL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -59.75.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BMGL stock in for the last two-week period is set at 19.51, with the RSI for the last a single of trading hit 13.72, and the three-weeks RSI is set at 24.02 for Basel Medical Group Ltd [BMGL]. The present Moving Average for the last 50 days of trading for this stock 4.37, while it was recorded at 4.12 for the last single week of trading.
Insight into Basel Medical Group Ltd Fundamentals:
Basel Medical Group Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.03 and a Current Ratio set at 2.04.
